A phase I study of IPH2101, a novel anti-inhibitory KIR monoclonal antibody, in patients with multiple myeloma
Benson, D. M., Padmanabhan, S., Hofmeister, C. C., Bakan, C. E., Abonour, R., Suvannasankha, A., Efebera, Y. A., Squiban, P. J., Caligiuri, M. A., Farag, S.
Published in Journal of clinical oncology (20.05.2010)
Published in Journal of clinical oncology (20.05.2010)
Get full text
Journal Article
Vγ9Vδ2 T (γδ) lymphocytes: a promising approach for immunotherapy of solid tumors
Squiban, P. J., Bompas, E., Bennouna, J., Levy, V., Sicard, H., Lafaye de Micheaux, S., Viey, E., Salot, S., Tiollier, J., Calvo, F.
Published in Journal of clinical oncology (20.06.2007)
Published in Journal of clinical oncology (20.06.2007)
Get full text
Journal Article